TITLE

Selling Out for Science

AUTHOR(S)
Guterl, Fred; Cunningham, Jaime; Raymond, Joan; Brownell, Ginanne
PUB. DATE
November 2004
SOURCE
Newsweek (Pacific Edition);11/8/2004 (Pacific Edition), Vol. 144 Issue 19, p46
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Focuses on the debate over stem cells in the United States. Claim that some scientists have exaggerated stem cells' potential for cures; Reference to a proposition in California that would give $3 billion to human embryonic stem cell research; Research conducted by Hans Kierstead of the University of California's Reeve-Irvine Research Center; Ethics surrounding the use of embryonic stem-cells in research; Obstacles faced by scientists in creating various types of tissue out of stem cells; Reference to an article in the June 2004 issue of "Scientific American," by Robert Lanza and Nadia Rosenthal.
ACCESSION #
16457674

 

Related Articles

  • Selling Out for Science. Guterl, Fred; Cunningham, Jaime; Raymond, Joan; Brownell, Ginanne // Newsweek (Atlantic Edition);11/8/2004 (Atlantic Edition), Vol. 144 Issue 19, p54 

    Focuses on the debate over stem cells in the United States. Claim that some scientists have exaggerated stem cells' potential for cures; Reference to a proposition in California that would give $3 billion to human embryonic stem cell research; Research conducted by Hans Kierstead of the...

  • Umbilical Cord Blood: A Unique Source of Pluripotent Stem Cells for Regenerative Medicine. Harris, David T.; Rogers, Ian // Current Stem Cell Research & Therapy;Dec2007, Vol. 2 Issue 4, p301 

    It is estimated that almost 1 in 3 individuals in the United States might benefit from regenerative medicine therapy. Unfortunately, embryonic stem (ES) cell therapies are currently limited by ethical, political, biological and regulatory hurdles. Thus, for the foreseeable future, the march of...

  • Stem Cells: The Future of Personalised Medicine? Irfan, Ahmer; Ahmed, Irfan // Medical Equipment Insights;2014, Issue 5, p1 

    After hitting the headlines in the 1960s, stem cell therapy has been the subject of great optimism in the treatment of many conditions. Discoveries of new procurement methods for various stem cells has allowed the technology and research to progress to a stage where real therapeutic alternatives...

  • THE STEM-CELL SAGA.  // Popular Science;Mar2012, Vol. 280 Issue 3, p88 

    The article discusses the history of embryonic stem cell research, examining objections to stem-cell research by anti-abortion activists as well as the approval of a clinical trial of stem-cell therapy by the U.S. Food and Drug Administration.

  • Stem Cell Therapy for Diabetes: Are We Close Enough? Kadam, Sachin S. // Journal of Krishna Institute of Medical Sciences (JKIMSU);Jan-Jun2014, Vol. 3 Issue 1, p6 

    Over the last few decades, understanding of the mechanism of cellular development has increased tremendously. The knowledge of the potential of stem/precursor cells in tissue engineering and cell therapy has gained the popularity. In case of diabetes, the availability of the source of stem cells...

  • Vatican Science Project.  // America;11/21/2011, Vol. 205 Issue 16, p4 

    In this article the author discusses the initiative taken by the Vatican to promote embryonic stem-cell research, which called a meeting of scientists on the stem-cell therapies, and the opposition shown by some scientists to the initiative due to suspicious intentions of the Vatican.

  • Presidential Election Result Good News for Stem Cell Sector. Winter, Peter // BioWorld Insight;11/12/2012, Vol. 20 Issue 46, p1 

    The article discusses positive impact of reappointment of the U.S. President Barack Obama who had overruled pre-existing executive orders regarding federal fund grants for pursuing human embryonic stem cells (hESC) research in the U.S. It mentions that easing of restrictions imposed on hESC...

  • Should Stem Cell Research Be Permitted? NO. Perkins, Tony // U.S. News Digital Weekly;3/13/2009, Vol. 1 Issue 8, p16 

    This article presents the views of Tony Perkins, president of the Family Research Council, on whether stem cell research should be permitted in the U.S. He cites some examples of patients who were treated successfully with stem cells. He points out that the stem cells used to treat these...

  • ISL1 Protein Transduction Promotes Cardiomyocyte Differentiation from Human Embryonic Stem Cells. Fonoudi, Hananeh; Yeganeh, Meghdad; Fattahi, Faranak; Ghazizadeh, Zaniar; Rassouli, Hassan; Alikhani, Mehdi; Mojarad, Bahareh Adhami; Baharvand, Hossein; Salekdeh, Ghasem Hosseini; Aghdami, Nasser // PLoS ONE;Jan2013, Vol. 8 Issue 1, Special section p1 

    Background: Human embryonic stem cells (hESCs) have the potential to provide an unlimited source of cardiomyocytes, which are invaluable resources for drug or toxicology screening, medical research, and cell therapy. Currently a number of obstacles exist such as the insufficient efficiency of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics